Chemic Labs and ASI Announce Joint Cooperation Agreement

CANTON, Mass. - May 15, 2014 - PRLog -- Canton, MA – May 15, 2014 - Chemic Laboratories Inc. and ASI today announced establishment of a formal three year Joint Cooperation Agreement that will enable the two firms to collaborate on a variety of Pharmaceutical and Biopharmaceutical client interests, primarily in the areas of product development as it pertains to extractables and leachables supporting Single-Use Systems (SUS). Under this agreement, the companies can now leverage their collective expertise in polymer film analytics, development, and commercial manufacturing to make a definitive difference in their client's business performance, substantially reducing the time needed to bring products to market and mitigating risk during the pharmaceutical & biopharmaceutical development process.

"Chemic is very pleased to establish this formal working relationship with ASI, which is poised to become a global leader in the area of Single-Use Technology said Joseph St. Laurent, President and CSO of Chemic Laboratories Inc. "This Joint Agreement places our two firms at the forefront of the rapidly expanding marketplace of companies that are seeking to further understand their pharmaceutical and biopharmaceutical products and the impact the SUS can have on these processes."

Carl Martin, Chief Executive Officer for ASI, commented that "Given the need for analytical data within the life Sciences and healthcare markets, we are confident that the collaboration with Chemic Laboratories will further enhance the support we provide to our customers. Additionally, our intent through this collaboration is to also foster the understanding of SUS in terms of impact and regulatory guidance.”

The cooperation model between the two companies will consist of ASI developing film products and Single-Use Systems for use by pharmaceutical and biopharmaceutical customers while Chemic will utilize well established and developed analytics to provide extractable data assessing material compatibility with model bioprocessing solutions as typically employed in pharmaceutical and biopharmaceutical processes. Developing detailed informational packages will allow SUS users to ¹⁾ streamline their processes, ²⁾ predict material compatibility, and ³⁾ move directly into leachable, migration and simulation investigations as applicable.

About Chemic Laboratories, Inc.:

Chemic Laboratories is a privately held full service FDA registered and DEA licensed, cGMP/ GLP Contract Chemistry Organization (CCO) founded in 1998. Chemic offers unparalleled contract analytical, API synthesis, and formulation development, to the pharmaceutical, biotech, and medical device industries. Chemic Laboratories offers these services by providing a strategically designed, highly technical facility, equipped with state of the art instrumentation. All programs can be conducted under the strict auspices of FDA and EMEA guidelines.

For more information contact:
Chemic Laboratories, Inc.
Client Services
480 Neponset Street, Bldg 7
Canton, MA 02021
781-821-5600
www.chemiclabs.com
customerservice@chemiclabs.com

About ASI:

ASI is a leading global provider of advanced single-use systems for the healthcare and life sciences industries. ASI’s fully customized systems and high-quality services offer the flexibility to maximize efficiency, minimize costs and alleviate risks in the production of bio-pharmaceutical processes and patient-care devices. ASI’s manufacturing and corporate headquarters are in Pennsylvania, United States with an additional production facility in Matamoros, Mexico. ASI’s ISO Class 7 and ISO Class 8 Clean Rooms are rigorously monitored through in-house quality management and third party audits. ASI single-use systems are manufactured in compliance to the ISO 13485:2003 Certification and FDA regulations.

For more information contact:
ASI
Press Contact: Amber Sherrick
Marketing Manager, ASI
163 Research Lane
Millersburg, PA
800-724-4158
717-692-2104